| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |